CFO
BCPC icon

Callan Family Office’s Balchem Corp BCPC Stock Holding History

Callan Family Office’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Sell
1,701
-3,395
-67% -$564K 0.01% 1021
2026
Q1 		$864K Buy
5,096
+870
+21% +$148K 0.02% 605
2025
Q4 		$648K Buy
+4,226
New +$645K 0.01% 687

Other funds holding BCPC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Callan Family Office's BCPC Position: Q2 2026 in Review

Callan Family Office reduced its Balchem Corp (BCPC) stake by 67% in Q2 2026, selling an estimated $564K and leaving 1,701 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #1021.

Callan Family Office first reported a position in BCPC in Q4 2025 and has held it in 3 quarters since. The position peaked at $864K in Q1 2026. 417 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • Callan Family Office held 1,701 shares of Balchem Corp worth $287K as of Q2 2026.
  • Callan Family Office sold 3,395 Balchem Corp shares in Q2 2026, an estimated $564K.
  • Balchem Corp made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #1021 holding.
  • Callan Family Office first reported a position in Balchem Corp in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Balchem Corp position peaked at $864K in Q1 2026.
  • 417 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.